We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J’s Rush To Market Made Mesh Patients Suffer, Jury Told

Law360, Philadelphia (April 16, 2019, 7:21 PM EDT) -- A Johnson & Johnson unit’s bid to protect its market dominance by rushing a pelvic mesh implant to market without sufficient clinical testing left a Philadelphia-area woman paying the price through...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.